Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).

Dr. Steven Gordon, Chairman of Cleveland Clinic’s Department of Infectious Diseases, discusses with Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, if patients should receive antibiotics to prevent infective endocarditis before dental procedures.

Dr. Heidi Szugye, Cleveland Clinic’s Breastfeeding Medicine Medical Director, and Dr. Suet Kam Lam, Cleveland Clinic’s Breastfeeding Medicine Assistant Medical Director, discuss the most recent policy statement on breastfeeding from the AAP and the impact on clinical guidance.

In a two part podcast, Dr. Benjamin Calhoun, Lineberger Comprehensive Cancer Center of University of North Carolina at Chapel Hill, and Dr. Holly Pederson, Cleveland Clinic, discuss evidence-based criteria needed for selecting patients for non-operative management of the benign high-risk, breast lesions and the potential challenges in implementing observation in all patient populations.

In a two part podcast, Dr. Benjamin Calhoun, Lineberger Comprehensive Cancer Center of University of North Carolina at Chapel Hill, and Dr. Holly Pederson, Cleveland Clinic, discuss evidence-based criteria needed for selecting patients for non-operative management of the benign high-risk, breast lesions and the potential challenges in implementing observation in all patient populations.

Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.